MPO and obesity due to melanocortin 4 receptor deficiency: Thus, this study aimed to evaluate the plasma MPO and ANGPTL6 levels in both obese and T2D patients and to assess their association with the biochemical markers of obesity, inflammation, and atherosclerosis.